UNSPSC 51121604: Pentaerythritol tetranitrate or pentaerithrityl tetranitrate

This classification denotes a vasodilating agent with the molecular formula C5H8N4O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 10L39TRG1Z, chemically known as 2,2-bis((nitrooxy)methyl)-1,3-propanediol dinitrate (ester) but generally known as pentaerithrityl tetranitrate, which bears US NIH Compound Identifier 6518. European Medicines Agency schedules Pentaerithrityl tetranitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09676MIG.

The term PENTAERITHRITYL TETRANITRATE is an International Non-Proprietary Name. World Health Organization schedules pentaerithrityl tetranitrate in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: O([N](=O)O)CC(CO[N](=O)O)(CO[N](=O)O)CO[N](=O)O.

UNSPSC 51121604 Pentaerythritol tetranitrate or pentaerithrityl tetranitrate is a Commodity code that nominally refers to a specific vasodilator and explosive precursor chemical, but recent state and local procurement activity shows the code is being applied to broader pharmaceutical and medical supply solicitations rather than the chemical compound itself. State and local buyers are using this code designation across emergency medical services, pharmacy benefit programs, and cooperative purchasing arrangements for generic pharmaceuticals and over-the-counter medications. Issuing bodies include city purchasing departments, state health agencies, and multistate cooperative purchasing alliances. The City of Tampa's Purchasing Department and the Texas Health and Human Services Commission represent the principal recent buyers, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) coordinating pharmaceutical procurement across participating state and local jurisdictions including Oregon.

Recent activity spans Florida, Texas, and Minnesota, with MMCAP's multistate cooperative extending procurement reach across participating agencies in multiple states. Representative opportunities include the City of Tampa Fire Rescue's sealed-bid IFB for Advanced Life Support Medications (Solicitation 26P00188, response due April 8, 2026, estimated value $40,000) requiring supply of Labetalol, Epinephrine, Adenosine, and Diltiazem vials with nine-month minimum expiration dates and ten-day delivery; MMCAP's RFP for Generic Multi-Source Pharmaceuticals and OTC Products (Solicitation S1070000015802, response due March 26, 2026, two-year term effective July 1, 2026) requiring manufacturing compliance with cGMP and Drug Supply Chain Security Act standards and pricing through authorized wholesalers; and the Texas Health and Human Services Commission's RFI (HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities outside traditional pharmacy benefit manager arrangements. The code shows active procurement momentum in emergency medical services supply chains and state pharmacy programs, though the mismatch between the nominal chemical code and the actual pharmaceutical-supply work being solicited suggests potential classification drift in state and local databases.